PR Newswire – Start of Day

Globe NewswirePhase III prevention trial showed subcutaneous administration of investigational antibody cocktail casirivimab and imdevimab reduced risk of symptomatic COVID-19...

Page 35 of 37 1 34 35 36 37

Other Newzz